ÂÜÀòÂÒÂ×

Carel Smit is an IP Strategy Advisor and Director of IP at Formo since 2020. From 2017 to 2021, they were the Founder of Biophile - Biosciences Ventures, IP & Strategy, a biosciences and medtech consultancy. Carel is also a Limited Partner at Nucleus Capital since 2021, a Non Executive Director at Biotome Pty Ltd since 2018, a Guest Lecturer at The University of Western Australia since 2012, a Co-Founder and Shareholder at Photizo Light Therapy - Photon Therapy Systems since 2005, a Founding Director and Patent & Trade Marks Attorney at Patenteur® | IP Attorneys since 2012, a Senior Intellectual Property Advisor at Rio Tinto since 2012, a Senior Patent Counsel and Business Development at ipernica ltd since 2011, and an IP Consultant and Business Development Manager at Wrays | Intellectual Property since 2008.

Carel Smit has a diverse educational background. Carel obtained a Master of Philosophy - MPhil in Bioscience Enterprise from the University of Cambridge, a Master's Degree in Master of Intellectual Property from the University of Technology Sydney, a Bachelor of Laws (LLB) in Law from the University of South Africa/Universiteit van Suid-Afrika, a M.Sc. in Genetics from the University of Pretoria/Universiteit van Pretoria, a B.Sc(Hons) in Genetics from the University of Pretoria/Universiteit van Pretoria, and a B.Sc. in Genetics from the University of Pretoria/Universiteit van Pretoria. Additionally, Carel Smit holds certifications as a Registered Australian Patent Attorney from the Professional Standards Board (obtained in November 2009), an Attorney of the High Court from the High Court of Northern Gauteng (obtained in November 2002), and a South African Patent Attorney from the SAIIPL - South African Institute of Intellectual Property Law (obtained in November 2002).